Notre Dame gift aids pharmacogenomics program at 曼彻斯特 University
The University of Notre Dame has donated a Sequenom MassARRAY Analyzer 4 System to 曼彻斯特 University for its master’s degree program in pharmacogenomics (PGx).
This donation enables 曼彻斯特 graduate students to gain experience with this advanced analytical platform. The system combines mass spectrometry, sensitive and robust chemistry, and advanced data analysis software to meet the assay design, validation and performance needs of genomic laboratories.
It is valued at $240,000.
“Adding this instrumentation to our laboratory capabilities will also expand research efforts in PGx, where we continue to examine the relationship between an individual’s DNA and their response to medications,” said 戴夫Kisor, professor and director of pharmacogenomics education at 曼彻斯特.
The instrument will broaden 曼彻斯特’s teaching and research capabilities.
“The analyzer allows us to further look at DNA in the context of epigenetics, and how genes are turned on or turned off,” said 嘉莉Hoefer, assistant professor of pharmaceutical sciences and pharmacogenomics.
Epigenetics is the study of changes in organisms caused by modification of gene expression rather than alteration of the genetic code itself.
曼彻斯特 continues to be a national leader in pharmacogenomics education. It started the nation’s first dedicated master’s degree in PGx in 2016 at its Fort 韦恩 campus. The program expanded to include an online format in 2018. Later that year, it introduced a dual-degree program in which pharmacy students can choose to simultaneously earn a master’s degree in pharmacogenomics along with their Pharm.D. It was the nation’s first such program.
The 曼彻斯特 PGx laboratory in Fort 韦恩 is utilized by on-campus, dual degree and online students for intensive laboratory experiences.
“The ability to expand education in the laboratory setting is critical as our graduates move to positions in the PGx industry, research laboratories and health care settings, where the field is expanding,Kisor说。. “This generous gift from Notre Dame speaks to a keen recognition that they could contribute to the education of students beyond their institution, and 曼彻斯特 is very appreciative of this contribution.”
Notre Dame acquired the analyzer from Agena Bioscience.
对于媒体来说
戴夫Kisor， BS，药学.D., FCP, professor and director of pharmacogenomics education, dfkisor@曼彻斯特.edu
嘉莉Hoefer, Ph.D., assistant professor of pharmaceutical sciences and pharmacogenomics, cchoefer@曼彻斯特.edu
About 曼彻斯特 University
曼彻斯特 University, with campuses in North 曼彻斯特 and Fort 韦恩, Ind., offers more than 70 areas of academic study to more than 1,400 students in undergraduate programs, a Master of Science in Pharmacogenomics, a Master of Athletic Training a four-year professional Doctor of Pharmacy and a four-year dual degree in pharmacy and pharmacogenomics. Learn more about the private, northern Indiana school at www.曼彻斯特.edu .
我们的使命
曼彻斯特 University respects the infinite worth of every individual and graduates persons of ability and conviction who draw upon their education and faith to lead principled, 富有成效的, and compassionate lives that improve the human condition.
报道Inside INdiana Business2019年5月